Clinical Trial Update: Efficacy and Tolerability of Ambroxol Lozenge 20 mf in Relieving Pain of Sore Throat in Pat. With Acute/Viralpharyngitis [Phase 3]

View source ↗

Summary

Phase 3 trial updating efficacy and tolerability of Ambroxol lozenge for sore throat relief in acute/pharyngitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pharyngitis

Drugs mentioned

• Ambroxol lozenge 20 mg (ambroxol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pharyngitis | Phase 3 | Status: COMPLETED